Ozanimod
【化學名】Ozanimod
【原研】Receptos
【用途】Ozanimod用于復發性多發性硬化癥（RMS），克羅恩病和結腸性潰瘍（UC）的治療。
奧扎莫德 Ozanimod
一、產品概述
Ozanimod由Receptos開發，目前屬于Celgene。Ozanimod目前處于治療復發性多發性硬化癥（RMS）的新藥上市申請（NDA）階段，以及治療克羅恩病和結腸性潰瘍（UC）的臨床三期試驗階段。
二、主要產品
Description | Structural Formula | CAS No. | Category |
 | 1306760-87-1 | API | |
(S)-1-amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride |  | 1213099-69-4 | Intermediate |
 | 258273-31-3 | Intermediate | |
 | 86864-60-0 | Intermediate |
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.